adamantane has been researched along with Gaucher Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aerts, JM; Aten, J; Bietrix, FM; Bijl, N; Boot, RG; Dekker, N; Groen, AK; Groener, J; Langeveld, M; Lombardo, E; Ottenhoff, R; Overkleeft, HS; Serlie, M; van Eijk, M; van Roomen, C; Wennekes, T | 1 |
| Barragán Monasterio, M; Berniakovich, I; Eguizábal, C; García Fernández, JM; González, F; Gort, L; Izpisua Belmonte, JC; Matalonga, L; Ortiz Mellet, C; Ribes, A; Tiscornia, G; Veiga, A; Vivas, EL | 1 |
| Kelly, JW; Sawkar, AR; Whalen, LJ; Wong, CH; Yu, Z | 1 |
1 review(s) available for adamantane and Gaucher Disease
| Article | Year |
|---|---|
Glycosphingolipids and insulin resistance.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Cardiovascular Diseases; Ceramides; Diabetes Mellitus, Type 2; Dioxanes; Disease Models, Animal; Fatty Acids; Fatty Liver; Gaucher Disease; Glucosyltransferases; Glycosphingolipids; Humans; Insulin Resistance; Metabolic Syndrome; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pyrrolidines; Receptor, Insulin; Signal Transduction | 2011 |
2 other study(ies) available for adamantane and Gaucher Disease
| Article | Year |
|---|---|
Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds.
Topics: 1-Deoxynojirimycin; Adamantane; Antigens, Differentiation; Base Sequence; Cell Differentiation; Cells, Cultured; DNA Mutational Analysis; Dopaminergic Neurons; Drug Evaluation, Preclinical; Enzyme Stability; Gaucher Disease; Gene Expression; Glucosylceramidase; Humans; Induced Pluripotent Stem Cells; Kruppel-Like Factor 4; Lysosomes; Macrophages; Oligonucleotide Array Sequence Analysis; Protein Transport; Small Molecule Libraries; Transcriptome | 2013 |
Isofagomine- and 2,5-anhydro-2,5-imino-D-glucitol-based glucocerebrosidase pharmacological chaperones for Gaucher disease intervention.
Topics: Adamantane; Cells, Cultured; Fibroblasts; Gaucher Disease; Glucosylceramidase; Humans; Imino Pyranoses; Lysosomes; Models, Molecular; Mutation; Piperidines; Sorbitol; Stereoisomerism; Structure-Activity Relationship | 2007 |